辛烷-2,4,6-三酮 | 61067-58-1

• 分子结构分类: 有机化合物 - 有机氧化合物
• 中文名称: 辛烷-2,4,6-三酮
• 英文名称: octane-2,4,6-trione
• CAS: 61067-58-1
• 化学式: C₈H₁₂O₃
• 分子量: 156.181
• InChiKey: KYWYXJJKXSANGZ-UHFFFAOYSA-N

物化性质

• 沸点：
  244.6±15.0 °C(Predicted)
• 密度：
  1.027±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  0.1
• 重原子数：
  11
• 可旋转键数：
  5
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.62
• 拓扑面积：
  51.2
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  辛烷-2,4,6-三酮 、 二氧化碳 生成 3,5,7-Trioxononansaeure
  参考文献：
  名称：

  Formation of trianions of 2,4,6-triketones. Synthesis of 3,5,7-triketo acids using lithium diisopropylamide

  摘要：

  DOI：

  10.1021/ja00440a047
• 作为产物：
  描述：

  丙酸乙酯 、 乙酰丙酮 生成 辛烷-2,4,6-三酮
  参考文献：
  名称：

  Formation of trianions of 2,4,6-triketones. Synthesis of 3,5,7-triketo acids using lithium diisopropylamide

  摘要：

  DOI：

  10.1021/ja00440a047

文献信息

• BETULONIC AND BETULINIC ACID DERIVATIVES
  申请人：Leunis Jean-Claude

  公开号：US20090068257A1

  公开（公告）日：2009-03-12

  The present invention relates to betulonic and betulinic acid derivatives and, in particular, to C-28 and C-3 derivatives. The present invention relates to betulonic acid esters, dihydro-betulonic acid esters, PAG-modified betulinic acid derivatives, and PAG-modified dihydro-betulinic acid derivatives. Betulinic acid and derivatives thereof may be bound to a poly(alkylene glycol) (PAG) such as poly(ethylene glycol). Binding may be via a linker, such as a diamine, an amino acid, a peptide, an ester or a carbonate. The compounds of the present invention may be used for the treatment of cancer or a viral infection. The present invention also provides pharmaceutical compositions comprising the compounds of the present invention. The present invention further provides processes for the preparation of the compounds of the present invention, for example, from betulin.

  本发明涉及白桦酸和白桦皮酸衍生物，特别是C-28和C-3衍生物。本发明涉及白桦酸酯、二氢白桦酸酯、PAG修饰的白桦皮酸衍生物和PAG修饰的二氢白桦皮酸衍生物。白桦皮酸及其衍生物可以与聚（烯基氧化物）（PAG）如聚（乙二醇）结合。结合可以通过连接剂，例如二胺、氨基酸、肽、酯或碳酸酯实现。本发明的化合物可用于癌症或病毒感染的治疗。本发明还提供了包含本发明化合物的制药组合物。本发明还提供了制备本发明化合物的方法，例如从白桦中制备。
• Acylations of Dilithio β-Diketones with Aliphatic Esters [ILL] Form 1,3,5-Triketones. Cyclizations to 4-Pyrones and 4-Pyridones
  作者：Stewart D. Work、Charles R. Hauser

  DOI：10.1021/jo01038a031

  日期：1963.3
• COMPOSITION AND POLYMER
  申请人：Asahi Kasei Kabushiki Kaisha

  公开号：EP2735581B1

  公开（公告）日：2021-07-14
• Immune Stimulatory Oligoribonucleotide Analogs Containing Modified Oligophosphate Moieties
  申请人：Debelak Harald

  公开号：US20100260788A1

  公开（公告）日：2010-10-14

  Immunostimulatory oligoribonucleotides (ORN) featuring 5′-triphosphates and various 5′-triphosphate analogs are provided. Also provided are physiologically acceptable salts of the immunostimulatory ORN and pharmaceutical compositions containing the immunostimulatory ORN of the invention. ORN of the invention are useful as adjuvants and can be combined with an antigen to promote an antigen-specific immune response. ORN of the invention are also particularly useful for promoting a Th1-type immune response. Also provided are methods of use of the compounds and pharmaceutical compositions of the invention to enhance an immune response in a subject, as well to treat a number of conditions including cancer, infection, allergy, and asthma, and to vaccinate a subject against an antigen.
• IMMUNE STIMULATORY OLIGORIBONUCLEOTIDE ANALOGS CONTAINING MODIFIED OLIGOPHOSPHATE MOIETIES
  申请人：AdiuTide Pharmaceuticals GmbH

  公开号：US20130164333A1

  公开（公告）日：2013-06-27

  Immunostimulatory oligoribonucleotides (ORN) featuring 5′-triphosphates and various 5′-triphosphate analogs are provided. Also provided are physiologically acceptable salts of the immunostimulatory ORN and pharmaceutical compositions containing the immunostimulatory ORN of the invention. ORN of the invention are useful as adjuvants and can be combined with an antigen to promote an antigen-specific immune response. ORN of the invention are also particularly useful for promoting a Th1-type immune response. Also provided are methods of use of the compounds and pharmaceutical compositions of the invention to enhance an immune response in a subject, as well to treat a number of conditions including cancer, infection, allergy, and asthma, and to vaccinate a subject against an antigen.